Bristol Myers Squibb Co (BMY)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $128.36B
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Latest financial period: June 30, 2026
Filed with the SEC: July 30, 2026
Estimated earnings date: October 29, 2026
Profit #285 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 80.6% | 77.5% | 44.5% | 41.0% |
Growth #1279 of 1484 companies
Payout #430 of 1484 companies
Safety #980 of 1484 companies
Price #161 of 1484 companies
